| abstract |
The invention relates to medicine, in particular to soft medicinal agents for external application (ointment, gels, emulsions, liniments) and can be used for treating thermal, solar and chemical burns of human beings and animals. The inventive pharmaceutical composition for treating burns is embodied in the form of a gel and contains an active substance N -(β-oxyethyl)-4, 6-dimethyldihydropyrimedon-2 (xymedon), a gel former, a moisture retaining agent and distilled water. The gel former can be embodied in the form of sodium, carboxymethylcellulose, sodium alginates or the mixture thereof and the moisture retaining agent is embodied in the form of glycerin. In the other embodiments, additionally to xymedon, the composition can contain an active substance in the form of silver nitrate or silver nitrate and sodium sulphacyl or levomycetin and succinic acid. The tests have proved the high efficiency of said composition, which meets all the medical and biological requirements of modem medicinal agents used for treating burns and wounds. The pharmaceutical composition is embodied in the form of a gel and can be used as highly efficient regenerating, wound-healing and micro-circulation improving means for treating infected burn wound. |